WFM
REGN icon

Wilmington Funds Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Wilmington Funds Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$8.23M Buy
29,150
+4,430
+18% +$1.31M 0.83% 14
2014
Q1 		$7.42M Buy
24,720
+500
+2% +$154K 0.81% 12
2013
Q4 		$6.67M Buy
24,220
+480
+2% +$138K 0.67% 17
2013
Q3 		$7.43M Sell
23,740
-2,110
-8% -$555K 0.72% 15
2013
Q2 		$5.81M Buy
+25,850
New +$6.02M 0.55% 36

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wilmington Funds Management's REGN Position: Q2 2014 in Review

Wilmington Funds Management increased its Regeneron Pharmaceuticals (REGN) stake by 18% in Q2 2014, buying an estimated $1.31M and bringing the position to 29,150 shares worth $8.23M. The position accounts for 0.83% of the portfolio, ranked #14.

Wilmington Funds Management first reported a position in REGN in Q2 2013 and has held it in 5 quarters since. 448 funds tracked by Wall St. Rank hold REGN as of Q2 2014.

  • Wilmington Funds Management held 29,150 shares of Regeneron Pharmaceuticals worth $8.23M as of Q2 2014.
  • Wilmington Funds Management bought 4,430 Regeneron Pharmaceuticals shares in Q2 2014, an estimated $1.31M.
  • Regeneron Pharmaceuticals made up 0.83% of Wilmington Funds Management's portfolio in Q2 2014, its #14 holding.
  • Wilmington Funds Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 5 quarters since.
  • 448 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2014.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.